 The high frequency of off-target activity in CRISPR-Cas9 is a concern for therapeutic and clinical applications, but strategies to minimize off-target cleavage can improve specificity and enable faithful interpretation of genome editing data. This article was authored by Xiao Weijian, Louis YT, Xiao Gangwang, and others.